SEALSQ Announces Strong Year End Financial Position

Financial Position - The company expects to end the year with a strong balance sheet and a cash position projected to exceed $85 million by January 3, 2025 [1] - The company recently raised gross proceeds of$60 million through multiple registered direct offerings, including a $10 million offering announced on December 12, 2024, and an additional$50 million raised through two subsequent offerings completed in December 2024 [21] - The company's total ordinary shares outstanding reached 93.8 million, and its market capitalization surpassed $700 million as of December 30, 2024 [21] Compliance and Financial Structure - The company regained compliance with Nasdaq's minimum bid price requirement, with its closing bid price being at least$1.00 for at least 10 consecutive business days prior to the January 28, 2025 deadline [2][5] - Legacy financing tools have been phased out, reflecting the company's strengthened financial position [5] - The company has successfully fulfilled its outstanding warrant obligations and will no longer be required to enter into a convertible loan facility, solidifying its balance sheet and supporting its long-term growth strategy [9][10] Strategic Initiatives - The company is focusing on developing state-of-the-art Quantum Resistant Cryptography and Semiconductors to address the security challenges posed by quantum computing [4] - The net proceeds from recent transactions will be used to accelerate the deployment of post-quantum semiconductor technology and Application-Specific Integrated Circuit (ASIC) capabilities in the U.S., while also supporting general corporate objectives [3] - The company is pioneering the development of Post-Quantum Semiconductors that provide robust, future-proof protection for sensitive data across various applications, including Multi-Factor Authentication tokens, Smart Energy, Medical and Healthcare Systems, Defense, IT Network Infrastructure, Automotive, and Industrial Automation and Control Systems [12] Warrant and Financing Details - The company agreed with the holders of its outstanding warrants to a one-off reduction in exercise price to $1.65 on the condition that all outstanding warrants are exercised by January 3, 2025 [17] - The first registered direct offering included a requirement to enter into a convertible loan for a value of$10 million on or before January 16, 2025, with potential adjustments to the warrant exercise price and quantity if the requirement was not met [14] - The company does not currently expect to enter into any further registered direct offering of ordinary shares for at least 60 days following the December 19, 2024 announcement, due to the financings raised [11]